- Home
- ADSE vs CGEM Comparison
ADSE vs CGEM Comparison
Compare ADSE & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADSE
- CGEM
- Stock Information
- Founded
- ADSE 1980
- CGEM 2016
- Country
- ADSE Ireland
- CGEM United States
- Employees
- ADSE N/A
- CGEM N/A
- Industry
- ADSE Industrial Specialties
- CGEM Biotechnology: Pharmaceutical Preparations
- Sector
- ADSE Consumer Discretionary
- CGEM Health Care
- Exchange
- ADSE Nasdaq
- CGEM Nasdaq
- Market Cap
- ADSE 807.1M
- CGEM 730.2M
- IPO Year
- ADSE N/A
- CGEM 2021
- Fundamental
- Price
- ADSE $14.78
- CGEM $9.03
- Analyst Decision
- ADSE Hold
- CGEM Strong Buy
- Analyst Count
- ADSE 1
- CGEM 7
- Target Price
- ADSE $14.00
- CGEM $32.50
- AVG Volume (30 Days)
- ADSE 193.5K
- CGEM 432.6K
- Earning Date
- ADSE 09-12-2024
- CGEM 03-13-2025
- Dividend Yield
- ADSE N/A
- CGEM N/A
- EPS Growth
- ADSE N/A
- CGEM N/A
- EPS
- ADSE N/A
- CGEM N/A
- Revenue
- ADSE $158,974,606.00
- CGEM N/A
- Revenue This Year
- ADSE $101.72
- CGEM N/A
- Revenue Next Year
- ADSE $55.77
- CGEM N/A
- P/E Ratio
- ADSE N/A
- CGEM N/A
- Revenue Growth
- ADSE 168.42
- CGEM N/A
- 52 Week Low
- ADSE $8.41
- CGEM $8.92
- 52 Week High
- ADSE $16.35
- CGEM $30.19
- Technical
- Relative Strength Index (RSI)
- ADSE 46.42
- CGEM 30.40
- Support Level
- ADSE $14.37
- CGEM $9.06
- Resistance Level
- ADSE $15.41
- CGEM $9.51
- Average True Range (ATR)
- ADSE 0.73
- CGEM 0.50
- MACD
- ADSE -0.04
- CGEM -0.05
- Stochastic Oscillator
- ADSE 46.58
- CGEM 6.18
About ADSE ADS-TEC ENERGY PLC
ADS-TEC Energy PLC produces, develops, and markets battery-buffered EV charging systems infrastructure, battery storage systems, and cloud-based services which enable the customer to control and manage the system. Geographically, it derives a majority of its revenue from Europe.
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, create differentiated ideas, identify the appropriate targets, and select the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications.